Deletion of the thymidine kinase gene induces complete attenuation of the Georgia isolate of African swine fever virus

African swine fever virus (ASFV) is the etiological agent of a contagious and often lethal viral disease of domestic pigs. There are no vaccines to control Africa swine fever (ASF). Experimental vaccines have been developed using genetically modified live attenuated ASFVs obtained by specifically deleting virus genes involved in virulence, including the thymidine kinase (TIC) gene. TIC has been shown to be involved in the virulence of several viruses, including ASFV. Here we report the construction of a recombinant virus (ASFV-G/V-Delta TK) obtained by deleting the TIC gene in a virulent strain of ASFV Georgia adapted to replicate in Vero cells (ASFV-GIVP30). ASFV-G/P-Delta TK demonstrated decreased replication both in primary swine macrophage cell cultures and in Vero cells compared with ASFV-G/VP30. In vivo, intramuscular administration of up to 106 TCID50 of ASFV-G/V-Delta TK does not result in ASF disease. However, these animals are not protected when challenged with the virulent parental Georgia strain. Published by Elsevier B.V.